Alnylam Pharmaceuticals Operating Income 2010-2025 | ALNY

Alnylam Pharmaceuticals operating income for the twelve months ending March 31, 2025 was $-0.115B, a 34.37% decline year-over-year.

  • Alnylam Pharmaceuticals annual operating income for 2024 was $-0.177B, a 37.31% decline from 2023.
  • Alnylam Pharmaceuticals annual operating income for 2023 was $-0.282B, a 64.06% decline from 2022.
  • Alnylam Pharmaceuticals annual operating income for 2022 was $-0.785B, a 10.78% increase from 2021.

Alnylam Pharmaceuticals Operating Income 2010-2025 | ALNY

  • Alnylam Pharmaceuticals annual operating income for 2024 was $-0.177B, a 37.31% decline from 2023.
  • Alnylam Pharmaceuticals annual operating income for 2023 was $-0.282B, a 64.06% decline from 2022.
  • Alnylam Pharmaceuticals annual operating income for 2022 was $-0.785B, a 10.78% increase from 2021.